Alnylam Pharmaceuticals Aktie
282,30
EUR
-1,20
EUR
-0,42
%
328,59
USD
-2,18
USD
-0,66
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung